匈牙利成为欧盟第一个批准使用中国疫苗的国家 Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU


匈牙利政府药品监管机构1月29日批准使用中国国药集团研发的新冠疫苗,该国成为首个批准使用中国疫苗的欧盟成员国。匈牙利总理欧尔班表示,他最相信中国生产的新冠疫苗,个人会选择中国疫苗。

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Hungary became the European Union’s first member to approve China’s Sinopharm COVID-19 vaccine, sealing a deal on Friday for 5 million doses just a week after becoming the first EU member to buy Russia’s Sputnik V vaccine.

匈牙利成为首个批准使用中国国药集团新冠疫苗的欧盟成员国,并在1月29日与中方签订了购买500万剂疫苗的正式合同。就在一周前,匈牙利成为首个购买俄罗斯“卫星V”新冠疫苗的欧盟成员国。

 

Foreign Minister Peter Szijjarto said the Sinopharm vaccines were enough to inoculate 2.5 million people, or about a quarter of its population, delivered in four batches over four months.

匈牙利外交部长彼得·西亚尔托说,中国国药集团研发的新冠疫苗将分4批在4个月内交付匈牙利,足够250万人接种,大约相当于匈牙利全国人口的四分之一。

 

Prime Minister Viktor Orban said he would personally opt to receive the Chinese vaccine, as he trusted it more than others.

匈牙利总理欧尔班表示,他最相信中国生产的新冠疫苗,个人会选择中国疫苗。

 

“I’m waiting for the Chinese vaccine, I trust in that the most,” Orban said. “Some people think about vaccines ideologically, and they need a western one and not an eastern one. I think the Chinese have known this virus for the longest, and they probably know it the best.”

他说:“我在等待中国疫苗,也最相信中国疫苗。有人以意识形态思维认为应该用西方而不是东方的疫苗。我认为中国人是最早认识这个病毒的,他们也最了解这个病毒。”

ideologically [ˌaɪdiəˈlɒdʒɪkli]:adv.思想上;意识形态上

 

Hungarian officials have criticised the EU for what they see as a slow vaccine roll-out, and in recent months have insisted that procuring vaccines developed in both western and eastern countries, such as Russia and China, would ensure that Hungarians get quick access to vaccinations.

匈牙利官员批评欧盟在疫苗采购和分配问题上动作缓慢,并在近几个月坚称,采购俄罗斯和中国等国家研发的疫苗,不管是来自西方还是东方,这将确保匈牙利人能迅速接种疫苗。

 

The announcement came a day after Hungary’s government issued a decree calling for a green light for any vaccine that had been administered to at least 1 million people in at least three other countries.

匈牙利政府在1月28日公布了一项法令,将对已经在至少3个其他国家接种百万以上人口的任何疫苗启动批准程序。

 

Millions of doses made by Sinopharm and Sinovac shipped around the world to developing countries, particularly in Asia and Latin America.

数百万剂中国国药集团和中国科兴生产的新冠疫苗被运往世界各地的发展中国家,尤其是在亚洲和拉丁美洲。

 

Meanwhile, EU countries, relying so far almost entirely on a vaccine from Pfizer, have fallen far behind Britain, the United States and a number of developing countries in rolling out vaccines.

与此同时,到目前为止几乎完全依赖辉瑞疫苗的欧盟国家,在疫苗接种方面已经远远落后于英国、美国和一些发展中国家。

 

Hungary’s drug regulator gave emergency use approval to the Sinopharm vaccine, rather than wait for the bloc’s European Medicines Agency (EMA) to give the go-ahead, adding it to a list that also includes the Pfizer, Moderna and AstraZeneca vaccines as well as Russia’s Sputnik-V shot.

匈牙利药品监管机构并未等待欧洲药品管理局(EMA)的批准,而是批准紧急使用中国国药集团研发的新冠疫苗,并将其与辉瑞、摩德纳、阿斯利康以及俄罗斯“卫星V”等新冠疫苗一同列入紧急使用名单。

go-ahead[ˈɡəʊ əhed]:n.批准,许可;放行信号

 

Premier Orban said the government monitored inoculations using the Chinese vaccine in neighbouring Serbia.

总理欧尔班说,匈牙利政府正密切关注邻国塞尔维亚接种中国疫苗的情况。

 

Asked whether it had completed its study before authorising the vaccine, the drug regulator OGYEI said it gave the green light because the shot fit the conditions in the government decree. It said it would continue to keep track of the vaccine.

当被问及在批准该疫苗之前是否完成了相关研究时,匈牙利药品监管机构OGYEI表示,之所以批准接种,是因为该疫苗符合政府法令。该机构表示将继续跟踪疫苗接种情况。

 

It said that another state organisation, the National Public Health Centre, would put each vaccine shipment through tests, adding that 16 million people worldwide had already received the Sinopharm jab safely.

该机构表示,另一个国家机构国家公共卫生中心将对每批疫苗进行检测,并补充称,全球已有1600万人安全地接种了国药集团的疫苗。

 

In Hungary, which has close to 10 million people, 364,909 people have been infected and 12,374 people have died of COVID-19 so far. The government has extended restrictions until March 1, including an 8 pm curfew and the closure of restaurants.

匈牙利总人口近1000万,新冠肺炎确诊病例达364909例,死亡病例12374例。政府将疫情封锁措施延长至3月1日,包括晚上8点后实行宵禁和关闭餐馆。

 

英文来源:路透社


上海久汇纺织科技有限公司

公司总机:021-58991190

销售业务部:

15601673666 胡女士

纺织新材料供应部:

18049721407 梁工

http://www.starpont.com 

EMAIL:

starpont@126.com

  • 2021潮流服装消费趋势报告(CBNData)
    CBNData联合淘宝直播ON MAP发布《2021潮流服装报告》,基于CBNData消费大数据,洞察在国潮、奥运主题大热的情况下,2021年潮流服装如何寻求增长。
  • 2021防晒趋势白皮书(CBNData)
    第一财经商业数据中心(CBNData)发布《2021防晒趋势白皮书》,分析防晒行业从市场格局到消费者需求的新变化,并总结出“全面防护、防养合一、效率至上、体验升级”四大防晒消费新趋势。
  • 2.4亿人想穿,一年订单猛涨133%,被嫌弃的黑丝又翻红了(CBNData)
    当女明星和爱豆们腿上长满了黑丝,这个前些年被嫌弃得不行的单品,如今又成了潮流风向标。
  • 淘宝直播2021年度报告(CBNData)
    2020年,直播进入了快速普及阶段,各个新品牌也纷纷开始带货。直播电商下半场,用户价值在何处?淘榜单、淘宝直播联合淘宝直播ON MAP推出的《淘宝直播2021年度报告​》,对淘宝直播的用户商业价值和货品品类进行了分析,以便品牌和商家了解行业新趋势。
  • 2021精致妈妈生活及消费趋势洞察(CBNData)
    CBNData联合复星发布《精致妈妈的生活“三重奏”——2021精致妈妈生活及消费趋势洞察》,报告以一群来自高线城市,兼顾高学历、高收入的精致妈妈为代表,通过调研精致妈妈们在不同场景下的需求,结合阿里巴巴消费大数据、公开数据及多场景数据,揭示了新时代精致妈妈如何在承担妈妈责任的同时正视自我,在舍得之间实现人生追求,并总结出了精致妈妈们消费的三大趋势。
  • 2021中国消费品牌发展报告(CBNData)
    阿里研究院发布《2021中国消费品牌发展报告》,研究发现,疫情过后消费者更多倾向于就近与居家自助服务,线上线下融合发展使得情境组合丰富多样,消费场景重要意义凸显。
  • 2022春夏上海时装周作品发布报名通道开启
    2022春夏上海时装周作品发布报名通道开启 ,可扫描二维码了解详情。
  • 如何快速有效地鉴别 纺纱工艺与纱线品种
    就是用眼看手摸来鉴别纤维的方法。原理是根据各种纤维的燃烧特性与外观形态、颜色、光泽、长短、粗细、强力、弹性、手感和含杂情况等,依靠人的感觉器官来定性鉴别纺织纤维的方法。此法能快速鉴别各种纺织原料,且不借助于仪器,极为实用。
  • 什么是天丝纱​?天丝纱的性能与特点​
    tencel(天丝)纤维是英国acocdis公司生产的lyocell纤维的商标名称,在我国注册中文名为"天丝",该纤维以木浆为原料经溶剂纺丝方法生产的一种崭新的纤维。它有棉的“舒适性、涤纶的“强度”、毛织物的“豪华美感”和真丝的“独特触感”及“柔软垂坠” ,无论在干或湿的状态下,均极具韧性。